Publications
80
Citations
70
Est. group size
—
Recurring co-author estimate
Active years
7
Publishing since 2018
Breanne Burgess conducts cancer biology research focused on the molecular mechanisms driving childhood and nerve-related tumors. Recent work examines how certain regulatory proteins (such as the transcriptional coactivator TAZ) contribute to the development of alveolar rhabdomyosarcoma, a soft-tissue cancer, and investigates the immune environment surrounding nerve sheath tumors linked to neurofibromatosis type 1 (NF1).
Publication activity was sparse through the late 2010s and rose sharply in 2023 and 2024, indicating a recent surge in output.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 5 venues
- Deciphering the Immune Microenvironment of NF1-associated Peripheral Nerve Sheath Tumors: Identifying Early Biomarkers of Disease Progression and Malignant Transformation
Proceedings of IMPRS · 2024
- Table S1 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S4 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S7 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S3 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S6 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Table S2 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Supplementary Table and Figure Legends from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S1 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S2 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S5 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Data from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Data from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Supplementary Table and Figure Legends from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Figure S5 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
2023
- Cancer Research×3
- Clinical Cancer Research×2
- Journal of Food Protection×1
- Tumor Biology×1
- Proceedings of IMPRS×1
- Emily White
Medicine · University of Michigan
- Li Jiang
Medicine · Indiana University
- Abbi E. Smith
Medicine · Indiana University
- Dana K. Mitchell
Medicine · Indiana University
- Melissa L. Fishel
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile